首页> 外文期刊>British Journal of Clinical Pharmacology >Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan.
【24h】

Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan.

机译:收缩时间间隔的变化-舒马普坦血液动力学效应的非侵入性标志物。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: This study assessed the use of systolic time intervals (STI) as a potential non-invasive marker of the haemodynamic effects of sumatriptan, a 5HT1 receptor agonist. METHODS: Twenty-six patients undergoing diagnostic cardiac catheterization participated. STIs were derived from haemodynamic pressure tracings at baseline, following placebo injection and following either subcutaneous (n=18) or intravenous injection (n=8) of sumatriptan. RESULTS: Sumatriptan (i.v. or s.c.) was associated with significant increases in mean arterial pressure (95% C.I. 9,14mmHg, P=0.0001), total electromechanical systole (95% C.I.8,36ms, P<0.0001), pre-ejection period (95%C.I. 8,21ms, P=0.0001) and left ventricular ejection time (95% C.I. 2,12ms, P=0.004). Conclusion STI responses were consistent with sumatriptan-induced changes in afterload. In summary, the measurement of STIs is a potential non-invasive method of investigating the influence of serotonergic compounds on the cardiovascular system.
机译:目的:这项研究评估了收缩时间间隔(STI)作为5HT1受体激动剂舒马曲坦的血液动力学作用的潜在非侵入性标志物的用途。方法:26例接受诊断性心导管检查的患者参加。 STI从舒马曲坦的安慰剂注射后和皮下注射(n = 18)或静脉注射(n = 8)时的血液动力学压力曲线得出。结果:舒马曲坦(静脉或皮下注射)与平均动脉压(95%CI 9,14mmHg,P = 0.0001),总机电收缩期(95%CI8,36ms,P <0.0001),射血前期显着增加有关(95%CI 2,12ms,P = 0.004)(95%CI 8,21ms,P = 0.0001)和左心室射血时间(95%CI 2,12ms,P = 0.004)。结论STI反应与舒马曲坦引起的后负荷变化一致。总之,STIs的测量是研究血清素能化合物对心血管系统影响的一种潜在的非侵入性方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号